Nature's Sunshine Products
Manufactures herbal nutrition and personal care products through a global direct-selling network.
Something off on this page? Send us feedback.
Profile
Manufactures and directly sells nutritional and personal care products through independent consultants under the Nature's Sunshine Products and Synergy WorldWide brands. The business is organized by geography, with sales weighted outside the United States and operating exposure to direct-selling rules, product regulation, local currencies, and China/Hong Kong ownership.
Manufactures and directly sells nutritional and personal care products under the Nature's Sunshine Products and Synergy WorldWide brands, with categories spanning general health, digestive, cardiovascular, immune, personal care, and weight management. Most products are made in Spanish Fork, Utah after bulk herbs and raw materials go through quality-control testing.
Organized by Asia, Europe, North America, and Latin America and Other, the business is more international than domestic, with the United States, Taiwan, Japan, and South Korea each material to sales. Independent consultants buy products for personal use or resale, and compensation is tied to product sales through their organizations.
Direct-selling rules, consultant conduct, dietary-supplement regulation, local-currency exposure, and direct ownership in China and Hong Kong shape the operating model.
Company facts
Key statistics
Year to date −32.2% · Average volume (30d) 202.7K
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Rating | Prior target | Target |
|---|---|---|---|---|---|
| Aug 10, 2026 | DA Davidson | Reiterate | Buy | $21 | $25 |
| May 8, 2026 | Canaccord Genuity | Target | $18 | $37 | |
| Oct 21, 2025 | D.A. Davidson | Target | $21 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 6, 2026Q2 FY26 | $0.27 | $0.21 | −22.2% | $123.7M | $117.0M | −5.4% | −19.47% |
| May 7, 2026Q1 FY26 | $0.21 | $0.30 | +46.3% | $122.2M | $122.9M | +0.6% | −1.30% |
| Mar 10, 2026Q4 FY25 | $0.19 | $0.30 | +62.2% | $121.5M | $123.8M | +1.9% | −1.28% |
| Nov 6, 2025Q3 FY25 | $0.19 | $0.36 | +89.5% | $121.6M | $128.3M | +5.5% | +30.52% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $113.2M | $114.8M | $128.3M | $123.8M | $122.9M | $117.0M | |
| Gross profit | $81.6M | $82.3M | $94.0M | $89.8M | $90.0M | $86.2M | |
| Operating income | $6.2M | $4.3M | $9.0M | $5.3M | $9.5M | $5.5M | |
| Net income | $4.7M | $5.3M | $5.3M | $4.1M | $5.1M | $3.5M | |
| Diluted EPS | $0.25 | $0.28 | $0.30 | $0.23 | $0.29 | $0.19 | |
| Gross margin | 72.1% | 71.7% | 73.3% | 72.5% | 73.2% | 73.7% | |
| Operating margin | 5.4% | 3.7% | 7.0% | 4.3% | 7.8% | 4.7% |
Fiscal years (4-quarter sums)FY21 $444.1M · FY22 $421.9M · FY23 $445.3M · FY24 $454.4M · FY25 $480.1M
Revenue by product · Q2 FY26
Revenue by geography · Q2 FY26
Balance sheet, Jun 30, 2026Cash & short-term investments $82.5M · Total debt $21.4M · Total assets $259.8M · Shareholders' equity $169.3M
Dividends
No dividends on record.
Ownership
Shares outstanding 17.58M · Float 16.59M · 94.3% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| Fosun Pharma USA Inc. · 10 percent owner | 2.85M | 16.23% | Form 4 | Jun 9, 2025 |
| Wynnefield Capital Inc | 2.47M | 14.07% | 13F | May 15, 2026 |
| Prescott Group Capital Management, L.L.C. · 10 percent owner | 1.94M | 11.06% | Form 4 | Aug 19, 2026 |
| BlackRock, Inc. | 1.06M | 6.05% | 13F | May 13, 2026 |
| Dimensional Fund Advisors LP | 895.4K | 5.09% | 13F | May 7, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Aug 17, 2026 | Prescott Group Capital Management, L.L.C. | 10 percent owner | +20,000 | $14.69 |
| Aug 10, 2026 | Prescott Group Capital Management, L.L.C. | 10 percent owner | +40,876 | $15.84 |
| Aug 7, 2026 | Prescott Group Capital Management, L.L.C. | 10 percent owner | +96,000 | $16.63 |
| Aug 6, 2026 | Prescott Group Capital Management, L.L.C. | 10 percent owner | +4,513 | $16.57 |
| Jun 12, 2026 | Kevin R. Herbert | officer: EVP & President, North America | −2,000 | $20.68 |
Peers
- USANA Health Sciences
Direct-selling nutrition and personal care across similar wellness markets
- Herbalife
Direct-selling nutrition peer with weight-management overlap
- Nu Skin
Affiliate-led beauty and wellness peer with Asia exposure
- LifeVantage
Smaller direct-selling wellness peer with supplement overlap
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Nature's Sunshine Products | $14.21 | −0.07% | $249.9M | 14.1 | 13.2 | 0.5 | +2.0% |
| USANA Health Sciences | $14.04 | +0.07% | $259.2M | — | 13.8 | 0.3 | −5.3% |
| Herbalife | $12.50 | +0.52% | $1.29B | 8.0 | 4.7 | 0.2 | +5.4% |
| Nu Skin | $4.85 | +0.21% | $235.5M | — | 5.0 | 0.2 | −17.1% |
| LifeVantage | $6.26 | −1.11% | $80.2M | 15.9 | 17.3 | 0.4 | −23.1% |
| Median | 12.0 | 9.4 | 0.3 | −11.2% |






